By Jeremy Appleton, ND, CNS
Healthnotes Newswire (March 30, 2006)—A combination of lactobacilli and other probiotic bacteria has been found to ease the symptoms of irritable bowel syndrome (IBS), according to Alimentary Pharmacology and Therapeutics (2005;22:387–94). This new study is the largest and longest clinical trial of probiotics for IBS to date; results of previous studies have been mixed.
The double-blind, placebo-controlled trial included 103 people with established IBS. Each person was randomly assigned to receive either one probiotic capsule (containing a blend of Lactobacillus rhamnosus GG, L. rhamnosus LC705, Bifidobacterium breve Bb99, and Propionibacterium freudenreichii ssp. shermanii JS) or one placebo capsule each day for six months. Gastrointestinal symptoms were recorded. Total symptoms in the probiotic group were reduced by 42% compared with 6% in the placebo group.
Sometimes referred to as “spastic colon,” IBS is a common gastrointestinal disorder, affecting 10 to 20% of the US population. It often causes significant discomfort, though it is not considered a serious health threat. IBS is considered a “functional disorder,” because it refers to an altered bodily function rather than a specific disease. IBS is not related to inflammatory bowel diseases, such as Crohn’s disease or ulcerative colitis. Typical symptoms include abdominal bloating and soreness, gas, and alternating diarrhea and constipation. The cause of IBS is unknown.
Probiotics are beneficial bacteria, many of which are normal inhabitants of the human intestinal tract. They are responsible for many functions, including manufacturing immune factors and preventing the growth of disease-causing bacteria in the gut. Lactobacilli and bifidobacteria are considered safe for both healthy and immunosuppressed people. Use of probiotic supplements has been associated with reduced incidences of cancer, gastroenteritis, and some allergic reactions. Several studies have shown that probiotic supplements effectively combat infectious diarrhea in children, antibiotic-associated diarrhea, and traveler’s diarrhea. The specific blend of probiotics used in this study is not commercially available at this time.
It is not known how probiotics reduce the symptoms of IBS. Imbalances of the intestinal flora have been associated with IBS. Such imbalances could cause altered fermentation in the gut, leading to increased gas production. By restoring balance, probiotics could thus quell one symptom of IBS. Another theory is that overabundance of the wrong types of bacteria can trigger inflammation, leading to chronic bowel irritability and disordered regulation of bowel function by the brain. Further studies are warranted to learn which probiotic bacteria, or combinations of probiotic bacteria, work best for IBS, and why.
Jeremy Appleton, ND, CNS, is a licensed naturopathic physician, certified nutrition specialist, and published author. Dr. Appleton was the Nutrition Department Chair at the National College of Naturopathic Medicine, has served on the faculty at Bastyr University of Natural Health Sciences, and is a former Healthnotes Senior Science Editor and a founding contributor to Healthnotes Newswire. He has worked extensively in scientific and regulatory affairs in the supplement industry and is now a consultant through his company Praxis Natural Products Consulting and Wellness Services.
Copyright © 2006 Healthnotes, Inc. All rights reserved. Republication or redistribution of the Healthnotes® content is expressly prohibited without the prior written consent of Healthnotes, Inc. Healthnotes Newswire is for educational or informational purposes only, and is not intended to diagnose or provide treatment for any condition. If you have any concerns about your own health, you should always consult with a healthcare professional. Healthnotes, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. HEALTHNOTES and the Healthnotes logo are registered trademarks of Healthnotes, Inc.